Category: Robertson
-
Today’s Idea: Valeo Pharma (VPH.C) Boasts an Impressive Portfolio and Achieves Significant Growth
Even during my university days, I would find myself grasping my chest, wheezing after a short 15-minute walk to campus. In terms of fitness, I would consider myself to be above average. With this in mind, I found it startling that I was struggling to do something as trivial as walking to class. Drenched in…
-
Plurilock Security (PLUR.V) finalizes patent pending with USPTO
Plurilock Security Inc. (PLUR.V) announced today that it has submitted documentation to finalize a patent pending with the United States Patent and Trademark Office (USPTO) that covers enhancement to the Company’s continuous authentication platform. “With the well-documented shift to remote work environments such as virtual desktops due to the COVID-19 pandemic, we felt it was…
-
Aequus Pharmaceuticals (AQS.V) Sees All, Partners with ReVision Therapeutics to Tackle Stargardt Disease
I have a bit of a sweet tooth. When I was little, my dad used to buy me those massive 64-ounce Jelly Belly containers from Costco. Even that wasn’t enough to satiate my craving for sugar seeing as I would finish the entire thing in just a few days. Eventually, I grew out of my…
-
Playgon Games (DEAL.V) goes live with Ballys
Playgon Games Inc. The COVID-19 pandemic has been a transformative experience, impacting almost every facet of life. From social distancing to wearing a mask, we have had to reconsider even the most trivial of tasks. As a certified hermit, the coronavirus didn’t pose too much of a threat to my secluded lifestyle. On the other…
-
Plurilock Security (PLUR.V) Receives MDA Purchase Order
Plurilock Security (PLUR.V) announced today that it has received a USD$219,000 purchase order from the U.S. Missile Defense Agency (MDA). This purchase order is part of the National Aeronautics and Space Administration’s (NASA) Solution for Enterprise-Wide Procurement (SEWP) program. If you’re new to Plurilock, let me give you a crash course on a few of…
-
Bionano Genomics (BNGO.Q) under the microscope, taking a look at a company you may have missed
Bionano Genomics (BNGO.Q) has been keeping busy lately, and the Company’s Q2 2021 Financial Results are a testament to their efforts. Bionano has been on my radar for quite some time, although I couldn’t really tell you why. After all, I don’t know the first thing about genomics, let alone science. In fact, I almost…
-
Bionano Genomics (BNGO.Q) under the microscope, taking a look at a company you may have missed
Bionano Genomics (BNGO.Q) has been keeping busy lately, and the Company’s Q2 2021 Financial Results are a testament to their efforts. Bionano has been on my radar for quite some time, although I couldn’t really tell you why. After all, I don’t know the first thing about genomics, let alone science. In fact, I almost…
-
Diagnos (ADK.V) Renews Contract with Optina Diagnostics
Diagnos (ADK.V) today announced a contract renewal to provide its telemedicine platform based on CARA (Computer Assisted Retina Analysis) to Optina Diagnostics for an additional three-year period. “This contract renewal is a testimony of the high quality of our telemedicine platform and the agility of DIAGNOS people to adapt its platform to enable the rich…
-
Today’s Idea: Medexus Pharmaceuticals (MDP.T) Continues to Climb the North American Pharmaceuticals Ladder
Cancer is a bitch. Even if you haven’t had to battle against cancer yourself, you likely know someone who has. Unfortunately for me, that person was my mom; however, before this turns into a sob story let me assure you that my mom is alive and well after kicking cancer’s ass. My mom was diagnosed…
-
Sector Review: Sprouting Seeds of the Plant-Based Market Featuring 4 Companies You May Have Missed
Week in Review My week was great, thanks for asking. In fact, I went on my first date since COVID-19 turned the world upside down. We made reservations for Burro, a local taco joint with some great food and drink options. Aside from my horribly degraded social skills, not that I had any to begin…